CA 125

Welcome to the Brand page for “CA 125”, which is offered here for Radioimmunoassays for ovarian cancer;.

Its status is currently believed to be active. Its class is unavailable. “CA 125” is believed to be currently owned by “CENTOCOR, INC.”

Competing brands may offer similar radioimmunoassays for ovarian cancer but may differ in terms of accuracy, sensitivity, specificity, and ease of use compared to CA 12CA 125 is considered good due to its active status and ownership by CENTOCOR, INC., a reputable company in the healthcare industry known for producing reliable diagnostic tools.

Owner:	CENTOCOR, INC. Owner Details
Description:	Radioimmunoassays for ovarian cancer;
Categories:	RADIOIMMUNOASSAYS OVARIAN CANCER